Medicare Part D

Op-Ed
Medicare enrollment form
August 16, 2023
The Wall Street Journal

The 5 Biggest Mistakes People Make When Picking a Medicare Plan

By Amitabh Chandra
Report
August 08, 2023
Social Science Research Network

Rationing Medicine Through Bureaucracy: Authorization Restrictions in Medicare

By Boris Vabson | Zarek Brot-Goldberg | Samantha Burn | Timothy Layton
Post
August 04, 2023
AEIdeas

Prior Authorization Reduces Net Costs of Medicare Part D

By Boris Vabson
Report
pharmaceuticals
July 06, 2023
American Economic Review

The Behavioral Foundations of Default Effects: Theory and Evidence from Medicare Part D

By Boris Vabson | Zarek C. Brot-Goldberg | Timothy Layton | Adelina Yanyue Wang
Article
Medicare enrollment form
June 14, 2023
Health Affairs Forefront

The Impact of Medicare Advantage Growth on Part D Competition, Costs, and Coverage

By Benedic N. Ippolito | Boris Vabson
Working Paper
June 13, 2023
AEI Economic Policy Working Paper Series

Drug Pricing Decisions and Insurance Coverage: Evidence from Medicare Part D

By Benedic N. Ippolito | Joseph F. Levy
Post
February 07, 2023
AEIdeas

How Medicare Shapes Drug Prices

By Benedic N. Ippolito | Joseph Levy
Journal Publication
Illustration photo shows various medicine pills in their original packaging in Brussels, Belgium August 9, 2019. Reuters
February 06, 2023
Health Services Research

The Influence of Medicare Part D on the List Pricing of Brand Drugs

By Benedic N. Ippolito | Joseph F. Levy
Event
Medicine pricing
December 09, 2022

How Will the Inflation Reduction Act Affect the Cost of Medicines for Patients?

By Kirsten Axelsen
Post
September 21, 2022
AEIdeas

Estimating Maximum Prices Under Medicare Negotiation in Part D

By Benedic N. Ippolito
Post
August 16, 2022
AEIdeas

Will the Inflation Reduction Act Make Drugs More Affordable?

By Kirsten Axelsen
Article
prescriptions at the pharmacy
February 17, 2022
The Incidental Economist

New Evidence Suggests a Lack of Cost-shifting in Prescription Drug Markets

By Benedic N. Ippolito | Loren Adler
Post
May 18, 2021
AEIdeas

The Variability of US Drug Prices: Lessons for Policy Debates

By Benedic N. Ippolito
Report
December 15, 2020
AEI Economic Perspectives

Medicare Part D Reforms: Who Wins and Who Loses?

By Joseph Antos | Kirsten Axelsen | Sara Rogers
Article
October 01, 2020
The Hill

Medicare Drug Discount Cards Will Be Future Disaster for Republicans

By Joseph Antos
Post
August 04, 2020
AEIdeas

New Report Shows a Majority of People Pay Less for Medicines Than Before

By Kirsten Axelsen
Post
April 21, 2020
AEIdeas

90-day Prescription Refills Are an Obvious Improvement. So Why Did It Take a Pandemic?

By Kirsten Axelsen | William S. Smith
Post
February 27, 2020
AEIdeas

A Cautionary Tale for Predicting Drug Prices

By Benedic N. Ippolito
Post
Medical equipment on top of money
July 24, 2019
AEIdeas

Evaluating the Senate Finance Committee Proposal to Restructure Medicare Part D

By Scott Gottlieb | Benedic N. Ippolito
Post
Medical equipment on top of money
March 05, 2019
AEIdeas

Finding Common Ground to Reduce Health Care Costs

By Benedic N. Ippolito
Article
A senior citizen woman reviews her notes while searching for medicare options on her laptop
August 03, 2018
RealClearPolicy

Base Medicare Premiums on Lifetime Earnings

By James C. Capretta
Article
January 22, 2014
Forbes

‘Risk Corridors’ in Obamacare Aren’t an Insurance Industry Bailout, but a Deliberate Subsidy. Why This Distinction Matters

By Scott Gottlieb
Article
October 11, 2013
Forbes

What Broke the Obamacare Web Site? The Need to Hide the Costs of the Health Plans

By Scott Gottlieb
Article
October 04, 2013
Forbes

President Obama Will Delay His Health Insurance Mandate

By Scott Gottlieb